Literature DB >> 25159235

Effect of preinfarction angina pectoris on long-term survival in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.

Tomohiko Taniguchi1, Hiroki Shiomi2, Toshiaki Toyota1, Takeshi Morimoto3, Masaharu Akao4, Kenji Nakatsuma1, Koh Ono1, Takeru Makiyama1, Satoshi Shizuta1, Yutaka Furukawa5, Yoshihisa Nakagawa6, Kenji Ando7, Kazushige Kadota8, Minoru Horie9, Takeshi Kimura1.   

Abstract

The influence of preinfarction angina pectoris (AP) on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI) remains controversial. In 5,429 patients with acute myocardial infarction (AMI) enrolled in the Coronary Revascularization Demonstrating Outcome Study in Kyoto AMI Registry, the present study population consisted of 3,476 patients with STEMI who underwent primary PCI within 24 hours of symptom onset and in whom the data on preinfarction AP were available. Preinfarction AP defined as AP occurring within 48 hours of hospital arrival was present in 675 patients (19.4%). Patients with preinfarction AP was younger and more often had anterior AMI and longer total ischemic time, whereas they less often had history of heart failure, atrial fibrillation, and shock presentation. The infarct size estimated by peak creatinine phosphokinase was significantly smaller in patients with than in patients without preinfarction AP (median [interquartile range] 2,141 [965 to 3,867] IU/L vs 2,462 [1,257 to 4,495] IU/L, p <0.001). The cumulative 5-year incidence of death was significantly lower in patients with preinfarction AP (12.4% vs 20.7%, p <0.001) with median follow-up interval of 1,845 days. After adjusting for confounders, preinfarction AP was independently associated with a lower risk for death (hazard ratio 0.69, 95% confidence interval 0.54 to 0.86, p = 0.001). The lower risk for 5-year mortality in patients with preinfarction AP was consistently observed across subgroups stratified by total ischemic time, initial Thrombolysis In Myocardial Infarction flow grade, hemodynamic status, infarct location, and diabetes mellitus. In conclusion, preinfarction AP was independently associated with lower 5-year mortality in patients with STEMI who underwent primary PCI.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25159235     DOI: 10.1016/j.amjcard.2014.07.038

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Influence of preinfarction angina and coronary collateral blood flow on the efficacy of remote ischaemic conditioning in patients with ST segment elevation myocardial infarction: post hoc subgroup analysis of a randomised controlled trial.

Authors:  Kasper Pryds; Morten Bøttcher; Astrid Drivsholm Sloth; Kim Munk; Michael Rahbek Schmidt; Hans Erik Bøtker
Journal:  BMJ Open       Date:  2016-11-24       Impact factor: 2.692

2.  Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies.

Authors:  Claudio Borghi; Stefano Omboni; Giorgio Reggiardo; Stefano Bacchelli; Daniela Degli Esposti; Ettore Ambrosioni
Journal:  J Cardiovasc Pharmacol       Date:  2017-01       Impact factor: 3.105

3.  Association Between Preinfarction Angina and Culprit Lesion Morphology in Patients With ST-Segment Elevation Myocardial Infarction: An Optical Coherence Tomography Study.

Authors:  Ying Wang; Zhaoxue Sheng; Jiannan Li; Yu Tan; Peng Zhou; Chen Liu; Xiaoxiao Zhao; Jinying Zhou; Runzhen Chen; Li Song; Hanjun Zhao; Hongbing Yan
Journal:  Front Cardiovasc Med       Date:  2022-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.